When we introduced Labs by Hims & Hers, we made it easier for customers to access biomarker results across areas of health that matter, then turn those insights into action.
Now, we are launching Labs AI, an AI care agent embedded in the Hims & Hers platform that makes customers’ lab results clearer, more useful, and easier to engage with. Using a custom-built AI system, Labs AI delivers personalized insights while helping address nuanced health questions.
Labs AI is customer-first by design. It complements providers’ clinical expertise by educating customers about their lab results, never diagnoses, and draws information from a curated medical knowledge base – not the open internet. Labs AI is the first agent in a broader AI ecosystem that we are building to support customers and clinicians alike. Many customers have access to Labs AI now, and we will roll it out to all Labs customers over time.
Labs AI is a purpose-built system that reasons across customers’ biomarker histories and personal health profiles to produce insights that are specific, safe, and actionable. It combines frontier language models with our in-house clinical knowledge base to serve as a health partner that is trustworthy and always available.
Importantly, Labs AI is grounded in proprietary, vetted, and safety-focused protocols developed with healthcare practitioners. It was built with clinician-designed guardrails and is continuously monitored for performance. This includes automated evaluations for accuracy and safety, and outputs are compared to clinician-reviewed rubrics for consistency. When models or protocols change, we regression-test performance against fixed benchmarks set by medical experts.
Using state-of-the-art learning techniques, Labs AI turns complexity into clarity, identifying patterns across up to 130 biomarker tests, why they matter, and how they fit into a broader picture of health.
For each customer, Labs AI assembles a structured profile that includes current and historical biomarker values, trends over time, demographic and lifestyle context, and prior care notes, when a customer chooses to share them. It reasons across that profile to surface patterns that may not be obvious from a single biomarker, like a testosterone value that reads differently in the context of sleep and stress results, or a cluster of results that suggest a broad metabolic trend that no single biomarker can show.
The output is more than just a summary of lab results. It is deep, personalized, and actionable analysis on whole body health, risks, and patterns that might otherwise go overlooked.
Customers don’t need to wait to ask questions after getting their results – they can discuss their biomarkers, health categories, and analytics directly with Labs AI. Labs AI responds to these questions quickly, sharing educational responses drawn from its expertly curated database of clinical information and protocols.
As an example, for a customer asking about heart health, Labs AI could explain how a pattern in their LDL cholesterol, ApoB, and lipoprotein(a) biomarkers indicates additional cardiovascular risk. As the customer follows up with more questions, Labs AI can generate personalized guidance on how aerobic activity, soluble fiber, and healthier fats could reduce that risk, as well as when to involve a licensed clinician.
Labs AI gives customers autonomy in their health journeys while keeping clinicians accessible. When biomarker results present concerns or when customers’ questions indicate the need to work with a provider, Labs AI proactively recommends they connect with a licensed clinician. Customers can easily connect with providers on the Hims & Hers platform about lab results, and Labs AI summaries are shared with care teams as part of that process.
That means no new intake process, no complex appointment scheduling, and no lost context – just continuity that makes the care experience more personalized and easier to navigate. Labs AI provides analysis and education while clinicians deliver diagnoses and medical recommendations.
.jpg)
Unlike general-purpose AI tools, Labs AI has one job: to help customers understand their health and act to improve it.
This is a preview of how we’re building AI across Hims & Hers: not as a layer on top of care, but as infrastructure inside it — shaped by clinicians, built into a platform customers trust, and measured by real improvements in understanding, action, and outcomes.
Cautionary Note Regarding Forward-Looking Statements
This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "anticipates," "expects," "intends," "plans," "decides," "may," "will," "likely," "potential," "future," "coming," "starting," "hope," or "should," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding the [Labs AI care agent embedded in the Hims & Hers platform, including its capabilities, availability, and the potential effects of AI-powered health insights on customer outcomes]. These statements are based on management's current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to[, the timing and logistical considerations related to the broader rollout of Labs AI and related AI capabilities on our platform, and the related customer response; the performance, accuracy, and safety of AI systems in clinical contexts; changes in the application, interpretation, and enforcement of healthcare, consumer protection, or privacy laws or regulations applicable to our business, including those relating to AI and digital health tools;] and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this communication are made only as of May 7, 2026. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication.
